Biomea Fusion, Inc. Form 10-Q: Quarterly report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2026-08-05: Form 10-Q; Period of report 2026-06-30; Description 10-Q; Document bmea-20260630.htm.
- 2026-05-11: Form 10-Q; Period of report 2026-03-31; Description 10-Q; Document bmea-20260331.htm.
- 2025-11-04: Form 10-Q; Period of report 2025-09-30; Description 10-Q; Document bmea-20250930.htm.
- 2025-08-05: Form 10-Q; Period of report 2025-06-30; Description 10-Q; Document bmea-20250630.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2026-08-05 | 10-Q | 2026-06-30 | 10-Q | bmea-20260630.htm |
| 2026-05-11 | 10-Q | 2026-03-31 | 10-Q | bmea-20260331.htm |
| 2025-11-04 | 10-Q | 2025-09-30 | 10-Q | bmea-20250930.htm |
| 2025-08-05 | 10-Q | 2025-06-30 | 10-Q | bmea-20250630.htm |
| 2025-05-05 | 10-Q | 2025-03-31 | 10-Q | bmea-20250331.htm |
| 2024-10-29 | 10-Q | 2024-09-30 | 10-Q | bmea-20240930.htm |
| 2024-07-31 | 10-Q | 2024-06-30 | 10-Q | bmea-20240630.htm |
| 2024-05-02 | 10-Q | 2024-03-31 | 10-Q | bmea-20240331.htm |
| 2023-10-30 | 10-Q | 2023-09-30 | 10-Q | bmea-20230930.htm |
| 2023-07-31 | 10-Q | 2023-06-30 | 10-Q | bmea-20230630.htm |
| 2023-05-02 | 10-Q | 2023-03-31 | 10-Q | bmea-20230331.htm |
| 2022-11-07 | 10-Q | 2022-09-30 | 10-Q | bmea-20220930.htm |
| 2022-08-01 | 10-Q | 2022-06-30 | 10-Q | bmea-20220630.htm |
| 2022-05-16 | 10-Q | 2022-03-31 | 10-Q | bmea-20220331.htm |
| 2021-11-03 | 10-Q | 2021-09-30 | 10-Q | bmea-10q_20210930.htm |
| 2021-08-11 | 10-Q | 2021-06-30 | 10-Q | bmea-10q_20210630.htm |
| 2021-05-27 | 10-Q | 2021-03-31 | 10-Q | bmea-10q_20210331.htm |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B |